Uncategorized
ADC biotech Sidewinder collects $137M for bispecific approach
A San Diego biotech looking to double up on the power of antibody-drug conjugates with fewer toxicities has patched together a $137 million Series B from a group of blue-chip investors.
The seven-employee startup, called …